Top Markets
Coin of the day
Pharmosa Biopharm Inc. Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.

6875
Rankning i aktier #20403
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Aktiekurs
$1.02
Marknadsvärde
$131.45M
Förändring (1 dag)
-0.62%
Förändring (1 år)
-37.92%
Land
TW
Handel Pharmosa Biopharm Inc. (6875)

Kategori

Aktiekurshistorik för Pharmosa Biopharm Inc. (6875)
Högsta slutkurs: $1.04 den 2026-08-01

Lägsta slutkurs: $1.60 den 2022-02-01
Aktiekurshistorik för Pharmosa Biopharm Inc. från 2022 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -19.43%
2025 1.72%
2024 -40.77%
2023 55.60%
2022 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.27 -15.19%
AU
$764.21 8.13%
CH